Table 1.
Binding partners of miRNAs in regulating oncogenesis.
Function | miRNA | Target | Effects | Ref. |
---|---|---|---|---|
Tumor suppressive (inhibition) | miR-26a | RNF6 | Proliferation | [53] |
CHD1, GREB1 and KPNA2 | [54] | |||
Metadherin | Proliferation and metastasis | [55] | ||
MCL-1 | [56] | |||
CCNE2 | Sensitize to trastuzumab in Her2+ subtype | [57] | ||
ERBB2 | Sensitize to tamoxifen in ER+ subtype | [58] | ||
miR-193a/b | DDAH1 | Angiogenesis | [172] | |
PTP1B | Proliferation and survival | [173] | ||
MORC4 | [174] | |||
WT1 | Proliferation and metastasis | [175] | ||
RAB22A | [176] | |||
MCL-1 | Sensitize to doxorubicin | [177] | ||
uPA | Proliferation, cell invasion and metastasis | [178] | ||
miR-216a/b | TLR4 | Suppresses stemness and the release of soluble factors associated with cancer-associated fibroblast activation | [194] | |
PKCα | Survival and migration | [195] | ||
PAK2 | Proliferation and metastasis | [196] | ||
SDCBP | [197] | |||
P2X7R | Proliferation and survival | [198] | ||
HDAC8 | Proliferation and colony formation | [199] | ||
miR-223 | Caprin-1 | Proliferation and invasion | [203] | |
STIM1 | [204] | |||
HAX-1 | Survival and sensitize to doxorubicin and cisplatin | [205] | ||
STAT5A | Survival and sensitize to paclitaxel | [206] | ||
EGF | Proliferation and sensitize radiation-treated breast cancer cells to lapatinib | [207] | ||
Oncogenic (promotion) | miR-1246 | CCNG2 | Proliferation, migration, chemoresistance to docetaxel, epirubicin and gemcitabine | [456] |
Abbreviations: Her2: human epidermal growth factor receptor 2; ER: estrogen receptor.